Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study’s listed results/measurement section has been updated, including endpoint time frames and the detailed wording of response and survival measures for cohorts 1–8 and cohort 9. It also reflects newer results posting/submission dates and study-document metadata updates rather than new study design elements like interventions, eligibility, or locations.SummaryDifference3%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check65 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedThe status changed from 'No Results Posted' to 'Results Submitted', indicating that results are being prepared/uploaded for the study record.SummaryDifference0.0%

- Check86 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check93 days agoChange DetectedFooter revision label updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.